Growth Metrics

OmniAb (OABI) Other Gross PP&E Adjustments (2021 - 2026)

OmniAb (OABI) reported Other Gross PP&E Adjustments of $4.8 million for Q1 2026, up 186.9% year-over-year from $1.7 million in Q1 2025, and down 63.32% on a QoQ basis from $13.0 million in Q4 2025.

OmniAb (OABI) has 6 years of Other Gross PP&E Adjustments data on file, last reported at $4.8 million in Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 186.9% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 186.9% YoY) and the FY2025 annual result came in at $13.0 million, up 296.48% from the prior year.
  • Other Gross PP&E Adjustments declined to $4.8 million in Q1 2026 per OABI's latest filing, from $13.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $13.0 million in Q4 2025 and bottomed at -$5.6 million in Q1 2023.
  • The 5-year median for Other Gross PP&E Adjustments is $2.6 million (2023), against an average of $3.0 million.
  • The widest annual swing landed in 2023, when Other Gross PP&E Adjustments soared 538.7%; it then soared 45.22% in 2025.
  • Tracing OABI's Other Gross PP&E Adjustments over 5 years: stood at $230000.0 in 2022, then soared by 538.7% to $1.5 million in 2023, then surged by 122.4% to $3.3 million in 2024, then jumped by 296.48% to $13.0 million in 2025, then slumped by 63.32% to $4.8 million in 2026.
  • Per Business Quant, the three latest OABI Other Gross PP&E Adjustments figures stand at $4.8 million (Q1 2026), $13.0 million (Q4 2025), and $9.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 4.75 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.75 Mn
Mar 31, 2026 4.75 Mn
Dec 31, 2025 12.95 Mn
Dec 31, 2025 12.95 Mn
Sep 30, 2025 9.53 Mn
Sep 30, 2025 9.53 Mn
Jun 30, 2025 5.66 Mn
Jun 30, 2025 5.66 Mn
Mar 31, 2025 1.66 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 3.27 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 6.56 Mn
Sep 30, 2024 6.56 Mn
Jun 30, 2024 2.64 Mn
Jun 30, 2024 2.64 Mn
Mar 31, 2024 -1.75 Mn
Mar 31, 2024 -1.75 Mn
Dec 31, 2023 1.47 Mn
Dec 31, 2023 1.47 Mn
Sep 30, 2023 2.61 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 -1.30 Mn
Jun 30, 2023 -1.30 Mn
Mar 31, 2023 -5.64 Mn
Mar 31, 2023 -5.64 Mn
Dec 31, 2022 230,000.00
Dec 31, 2022 230,000.00
Dec 31, 2021 -4.95 Mn
Dec 31, 2021 -4.95 Mn